Back

Evidence-based novel therapies in HCM

11 May 2024 (10:10 - 10:20)
Organised by: Logo
Congress Presentation Part of: Staging therapy in hypertrophic cardiomyopathy patients with heart failure: new insights Hypertrophic Cardiomyopathy Open Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Michelle Michels

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor P. Seferovic (Belgrade, RS)
Slides
Presentation thumbnail
Recognition and diagnosing heart failure in patients with HCM
Professor A. Linhart (Prague, CZ)
Slides
Presentation thumbnail
Optimal pharmacological management of HCM by clinical manifestations
Doctor P. Garcia-Pavia (Majadahonda, ES)
Slides
Presentation thumbnail
Panel discussion and Q&A
Professor P. Seferovic (Belgrade, RS)
Slides

Access the full session

Session thumbnail
Staging therapy in hypertrophic cardiomyopathy patients with heart failure: new insights
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 10:10 CET
You may be interested in
thumbnail
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
17 May 2025
thumbnail
Webinar
How to implement new heart failure therapies in clinical practice
1 December 2022
thumbnail
Congress Presentation
Introduction
30 August 2025
thumbnail
Congress Presentation
Long-term safety and effectiveness of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) patients (pts): update from PIONEER open-label extension (PIONEER-OLE) study
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources